Clinical Trials Logo

Clinical Trial Summary

Chronic bronchopulmonary dysplasia (BPD) is a very common complication in preterm infants born at a young gestational age, and is a serious disease that impairs respiratory long-term outcome and is associated with higher-frequency neurodevelopmental injury. Lowering the incidence of BPD may improve the health of the preterm babies and neurodevelopmental delay of preterm infants.Vitamin A deficiency may be one of the factors associated with the development of BPD in preterm infants. According to the literature, oral vitamin A administration can lower the incidence of BPD. In our study we plan to give 5000 units of retinol / dose / day, every day for 28 days.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • The Relationship Between Oral Vitamin A Administration and the Incidence of BPD in Preterm Infants Born Before Week 29 of Pregnancy

NCT number NCT04563429
Study type Interventional
Source Sheba Medical Center
Contact Leah Leibovitch, MD
Phone +972526667325
Email leah.leibovitch@sheba.health.gov.il
Status Not yet recruiting
Phase N/A
Start date October 1, 2020
Completion date October 1, 2023